Hydroxychloroquine and Chloroquine.
Chen X.
Clin Infect Dis · letter; comment · DOI 10.1093/cid/ciaa338 PUBLICATION REGISTRY
Go to research.
Publikationsdata från Europe PMC och PubMed. Följ källhänvisningar från ämnesregistret till originalpublikationerna.
Publikationer som ChEBI hänvisar till för hydroxychloroquine. Visa hela publikationsregistret
A publication hit is not a conclusion. Publikationslistan visar bibliografiska uppgifter. Eventuella forskningsutdrag visas separat med originalunderlag. En källhänvisning visar inte i sig effekt, dosering eller säkerhet.
Publications in the selection
16 hitsCan hydroxychloroquine protect patients with rheumatic diseases from COVID-19? Response to: 'Does hydroxychloroquine prevent the transmission of COVID-19?' by Heldwein and Calado and 'SLE, hydroxychloroquine and no SLE patients with COVID-19: a comment' by Joob and Wiwanitkit.
Monti S, Montecucco C.
Ann Rheum Dis · letter; comment · DOI 10.1136/annrheumdis-2020-217524Hydroxychloroquine prophylaxis for COVID-19 contacts in India.
Rathi S, Ish P, Kalantri A, Kalantri S.
Lancet Infect Dis · letter; journal article · DOI 10.1016/s1473-3099(20)30313-3Does hydroxychloroquine prevent the transmission of COVID-19?
Heldwein FL, Calado A.
Ann Rheum Dis · letter; comment · DOI 10.1136/annrheumdis-2020-217501Hydroxychloroquine and COVID-19.
Sinha N, Balayla G.
Postgrad Med J · review-article; review; journal article · DOI 10.1136/postgradmedj-2020-137785Hydroxychloroquine use during the COVID-19 pandemic 2020.
Mack HG.
Aust J Gen Pract · journal article · DOI 10.31128/ajgp-covid-08Does hydroxychloroquine combat COVID-19? A timeline of evidence.
Alia E, Grant-Kels JM.
J Am Acad Dermatol · letter · DOI 10.1016/j.jaad.2020.04.031Chloroquine and hydroxychloroquine in covid-19.
Ferner RE, Aronson JK.
BMJ · editorial · DOI 10.1136/bmj.m1432Antithrombotic effects of hydroxychloroquine in primary antiphospholipid syndrome patients.
Schmidt-Tanguy A, Voswinkel J, Henrion D, Subra JF, Loufrani L, Rohmer V, Ifrah N, Belizna C.
J Thromb Haemost · letter · DOI 10.1111/jth.12363Long-term response to hydroxychloroquine in patients with discoid lupus erythematosus.
Wahie S, Meggitt SJ.
Br J Dermatol · research support, non-u.s. gov't; multicenter study; journal article · DOI 10.1111/bjd.12378Progression of hydroxychloroquine toxic effects after drug therapy cessation: new evidence from multimodal imaging.
Mititelu M, Wong BJ, Brenner M, Bryar PJ, Jampol LM, Fawzi AA.
JAMA Ophthalmol · journal article · DOI 10.1001/jamaophthalmol.2013.4244Hydroxychloroquine decreases Th17-related cytokines in systemic lupus erythematosus and rheumatoid arthritis patients.
Silva JC, Mariz HA, Rocha LF, Oliveira PS, Dantas AT, Duarte AL, Pitta Ida R, Galdino SL, Pitta MG.
Clinics (Sao Paulo) · research support, non-u.s. gov't; research-article; journal article · DOI 10.6061/clinics/2013(06)07Multifaceted effects of hydroxychloroquine in human disease.
Olsen NJ, Schleich MA, Karp DR.
Semin Arthritis Rheum · research support, non-u.s. gov't; systematic review; journal article; research support, n.i.h., extramural · DOI 10.1016/j.semarthrit.2013.01.001A rapid and reliable method for the quantitation of hydroxychloroquine in serum using turbulent flow liquid chromatography-tandem mass spectrometry.
Füzéry AK, Breaud AR, Emezienna N, Schools S, Clarke WA.
Clin Chim Acta · journal article · DOI 10.1016/j.cca.2013.02.018Experience with the use of hydroxychloroquine for the treatment of lupus erythematosus.
Momose Y, Arai S, Eto H, Kishimoto M, Okada M.
J Dermatol · journal article; case reports · DOI 10.1111/1346-8138.12005Impact of the revised american academy of ophthalmology guidelines regarding hydroxychloroquine screening on actual practice.
Browning DJ.
Am J Ophthalmol · multicenter study; journal article · DOI 10.1016/j.ajo.2012.09.025